[Current trends in anticoagulant and thrombolytic therapy of thrombosis].
D000925:Anticoagulants / Q000627:therapeutic use*; D001230:Aspergillus / Q000201:enzymology; D001241:Aspirin / Q000627:therapeutic use; D001954:Brinolase / Q000627:therapeutic use; D003374:Coumarins / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D004341:Drug Evaluation; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D010447:Peptide Hydrolases / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000188:drug therapy; D013927:Thrombosis / Q000188:drug therapy* / Q000517:prevention & control; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D004176:Dipyridamole; D006493:Heparin; D010447:Peptide Hydrolases; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator; D001954:Brinolase; D001241:Aspirin
Sovremennye napravleniia antikoaguliarnoĭ i tromboliticheskoĭ terapii trombozov